Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Brief Report
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Use advanced search instead (articles only)
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Infectious Diseases
Vol. 1, Issue 1, 2013
June 05, 2013 EDT
Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary
Raymond Odhiambo
,
Jagpreet Chhatwal
,
Shannon Allen Ferrante
,
Antoine El Khoury
,
Elamin Elbasha
,
ribavirin
peginterferon
markov model
cost-effectiveness
boceprevir
chronic hepatitis c
Copyright Logo
ccby-4.0
•
https://doi.org/10.36469/9854
JHEOR
1.
Odhiambo R, Chhatwal J, Ferrante SA, El Khoury A, Elbasha E. Economic Evaluation of Boceprevir for the Treatment of Patients with Genotype 1 Chronic Hepatitis C Virus Infection in Hungary.
JHEOR
. 2013;1(1):62-82.
doi:10.36469/9854
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats